Seth J. Baum MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Preventive Cardiology
Preventive Cardiology, Inc. Lipidologist Author, Lecturer Consultant
Join to View Full Profile
7900 Glades RdSuite 400Boca Raton, FL 33434
Phone+1 561-488-5535
Fax+1 561-488-2150
Dr. Baum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Cardiovascular Disease, 1988 - 1990
NYU Grossman School of MedicineInternship, Internal Medicine, 1985 - 1986
Columbia University Vagelos College of Physicians and SurgeonsClass of 1985
Certifications & Licensure
FL State Medical License 1991 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress Start of enrollment: 2016 Feb 01
- Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients Start of enrollment: 2019 Dec 04
- Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia Start of enrollment: 2021 Feb 16
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOlpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study.Gurleen Kaur, Robert S Rosenson, Baris Gencer, J Antonio G López, Norman E Lepor
European Heart Journal. 2025-03-24 - 2 citationsEffects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity.Michael R Zile, Barry A Borlaug, Christopher M Kramer, Seth J Baum, Sheldon E Litwin
Circulation. 2025-03-11 - Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial.Robert S Rosenson, J Antonio G López, Daniel Gaudet, Seth J Baum, Elmer Stout
JAMA Cardiology. 2025-02-12
Journal Articles
- The Present and Future JACC Scientific Expert Panel Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert PanelJoshua W Knowles, Seth J Baum, MacRae F Linton, Nathan O Stitziel, Daniel J Rader, Samuel S Gidding, Ray E Hershberger, Zahid S Ahmad, Christie M Ballantyne, ScienceDirect
Press Mentions
Medscape and ACC Centers of ExcellenceNovember 2nd, 2021- Madrigal Pharmaceuticals to Present Secondary Analyses of Data from Phase 2 NASH Study of Resmetirom and Symposium at the Digital International Liver Congress™ 2020August 26th, 2020
Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV EventsJuly 25th, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
